Structural Neuroimaging and Molecular Signatures of Drug‐Naive Depression With Melancholic Features
Lijin Yuan(Kunming Medical University), Zonglin Shen(Kunming Medical University), Mengxin He(Kunming Medical University), Zhaosong Chu(Kunming Medical University), Yi Lu(Shandong Provincial Hospital), Xianyu Chen(Kunming Medical University), Xiufeng Xu(Kunming Medical University)
Cited by 7
Related Papers
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
|JAMA Oncology|2019|1k
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
|The Lancet Psychiatry|2021|826
The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China
|Schizophrenia Research|2015|320
Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
|Schizophrenia Research|2014|136
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study
|Therapeutic Advances in Medical Oncology|2020|110